| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mitosis | 57 | 2025 | 114 | 13.290 |
Why?
|
| Cell Cycle Proteins | 51 | 2025 | 241 | 13.100 |
Why?
|
| Microtubules | 37 | 2025 | 121 | 10.920 |
Why?
|
| Kinetochores | 41 | 2025 | 44 | 9.220 |
Why?
|
| Chromosome Segregation | 37 | 2025 | 45 | 9.200 |
Why?
|
| Microtubule-Associated Proteins | 27 | 2025 | 95 | 9.130 |
Why?
|
| Chromosomal Proteins, Non-Histone | 31 | 2025 | 65 | 6.780 |
Why?
|
| Hela Cells | 70 | 2025 | 376 | 5.550 |
Why?
|
| Chromosomes, Human | 16 | 2025 | 37 | 4.940 |
Why?
|
| Parietal Cells, Gastric | 17 | 2019 | 19 | 4.390 |
Why?
|
| Proto-Oncogene Proteins | 13 | 2024 | 257 | 4.160 |
Why?
|
| Phosphorylation | 56 | 2026 | 986 | 3.880 |
Why?
|
| Cytoskeletal Proteins | 23 | 2020 | 116 | 3.440 |
Why?
|
| GTPase-Activating Proteins | 11 | 2025 | 29 | 3.240 |
Why?
|
| Nuclear Proteins | 16 | 2019 | 333 | 3.110 |
Why?
|
| Cell Movement | 19 | 2025 | 655 | 3.100 |
Why?
|
| Centromere | 15 | 2024 | 21 | 3.100 |
Why?
|
| Protein Binding | 53 | 2025 | 1082 | 2.970 |
Why?
|
| Humans | 176 | 2025 | 43102 | 2.380 |
Why?
|
| Schizosaccharomyces | 12 | 2026 | 17 | 2.210 |
Why?
|
| Phosphoproteins | 15 | 2013 | 206 | 2.210 |
Why?
|
| Cell Polarity | 9 | 2025 | 57 | 2.200 |
Why?
|
| Protein Processing, Post-Translational | 15 | 2024 | 185 | 2.030 |
Why?
|
| Signal Transduction | 23 | 2025 | 2157 | 1.790 |
Why?
|
| Schizosaccharomyces pombe Proteins | 10 | 2026 | 14 | 1.740 |
Why?
|
| Cell Membrane | 11 | 2021 | 403 | 1.640 |
Why?
|
| Protein Structure, Tertiary | 19 | 2015 | 423 | 1.640 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 10 | 2015 | 74 | 1.620 |
Why?
|
| Proteins | 13 | 2024 | 382 | 1.560 |
Why?
|
| Software | 10 | 2010 | 236 | 1.560 |
Why?
|
| Models, Biological | 14 | 2020 | 712 | 1.560 |
Why?
|
| Cell Division | 11 | 2024 | 311 | 1.550 |
Why?
|
| Centrosome | 6 | 2018 | 30 | 1.430 |
Why?
|
| Tumor Suppressor Proteins | 8 | 2013 | 223 | 1.380 |
Why?
|
| Cell Nucleus | 4 | 2023 | 383 | 1.370 |
Why?
|
| Animals | 66 | 2025 | 16992 | 1.370 |
Why?
|
| Membrane Proteins | 9 | 2018 | 561 | 1.350 |
Why?
|
| H(+)-K(+)-Exchanging ATPase | 7 | 2017 | 9 | 1.340 |
Why?
|
| DNA-Binding Proteins | 9 | 2022 | 561 | 1.330 |
Why?
|
| Amino Acid Sequence | 23 | 2021 | 1180 | 1.320 |
Why?
|
| Sequence Analysis, Protein | 6 | 2009 | 52 | 1.260 |
Why?
|
| Computational Biology | 8 | 2017 | 327 | 1.220 |
Why?
|
| Actins | 6 | 2025 | 164 | 1.210 |
Why?
|
| Protein Kinases | 8 | 2018 | 100 | 1.190 |
Why?
|
| Models, Molecular | 14 | 2025 | 876 | 1.170 |
Why?
|
| Metaphase | 5 | 2016 | 7 | 1.160 |
Why?
|
| Gastric Acid | 6 | 2015 | 11 | 1.140 |
Why?
|
| RNA, Small Interfering | 19 | 2021 | 436 | 1.140 |
Why?
|
| Anaphase | 6 | 2020 | 7 | 1.090 |
Why?
|
| Transcription Factors | 8 | 2025 | 735 | 1.070 |
Why?
|
| Mitochondria | 8 | 2026 | 523 | 1.070 |
Why?
|
| Protein-Tyrosine Kinases | 5 | 2020 | 139 | 1.020 |
Why?
|
| ADP-Ribosylation Factors | 5 | 2025 | 14 | 1.020 |
Why?
|
| Rabbits | 17 | 2017 | 278 | 0.980 |
Why?
|
| Carrier Proteins | 8 | 2025 | 321 | 0.950 |
Why?
|
| Cell Line, Tumor | 23 | 2025 | 2676 | 0.950 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2025 | 299 | 0.940 |
Why?
|
| p300-CBP Transcription Factors | 3 | 2018 | 14 | 0.930 |
Why?
|
| Cytokinesis | 5 | 2022 | 10 | 0.880 |
Why?
|
| Epithelial Cells | 6 | 2025 | 434 | 0.860 |
Why?
|
| Histamine | 4 | 2015 | 19 | 0.860 |
Why?
|
| Protein Transport | 9 | 2018 | 296 | 0.860 |
Why?
|
| Histone Acetyltransferases | 3 | 2016 | 21 | 0.860 |
Why?
|
| Cell Line | 16 | 2018 | 1410 | 0.850 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2020 | 49 | 0.840 |
Why?
|
| Lysine | 7 | 2024 | 119 | 0.840 |
Why?
|
| Algorithms | 12 | 2012 | 509 | 0.840 |
Why?
|
| Sirtuin 1 | 2 | 2021 | 34 | 0.830 |
Why?
|
| Helicobacter Infections | 2 | 2019 | 86 | 0.830 |
Why?
|
| Feedback, Physiological | 2 | 2021 | 32 | 0.820 |
Why?
|
| Kidney Neoplasms | 3 | 2020 | 80 | 0.820 |
Why?
|
| Helicobacter pylori | 2 | 2019 | 118 | 0.820 |
Why?
|
| Neoplasms | 6 | 2024 | 1377 | 0.810 |
Why?
|
| Leukemia | 1 | 2023 | 54 | 0.800 |
Why?
|
| Repressor Proteins | 7 | 2024 | 273 | 0.800 |
Why?
|
| G2 Phase | 3 | 2020 | 28 | 0.780 |
Why?
|
| Drosophila Proteins | 3 | 2024 | 188 | 0.780 |
Why?
|
| Amino Acid Motifs | 6 | 2023 | 97 | 0.770 |
Why?
|
| Acetylation | 9 | 2022 | 107 | 0.760 |
Why?
|
| Qa-SNARE Proteins | 3 | 2014 | 9 | 0.760 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 5 | 2016 | 15 | 0.760 |
Why?
|
| Organoids | 4 | 2024 | 37 | 0.720 |
Why?
|
| Neoplasm Invasiveness | 5 | 2018 | 290 | 0.710 |
Why?
|
| Catenins | 1 | 2021 | 5 | 0.710 |
Why?
|
| Stomach Neoplasms | 6 | 2024 | 241 | 0.700 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2025 | 163 | 0.700 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2020 | 20 | 0.700 |
Why?
|
| Databases, Protein | 7 | 2017 | 54 | 0.690 |
Why?
|
| Recombinant Fusion Proteins | 12 | 2017 | 296 | 0.690 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2025 | 968 | 0.690 |
Why?
|
| Methyltransferases | 3 | 2025 | 68 | 0.690 |
Why?
|
| Binding Sites | 16 | 2021 | 671 | 0.670 |
Why?
|
| ras GTPase-Activating Proteins | 2 | 2015 | 3 | 0.670 |
Why?
|
| Disease | 1 | 2020 | 21 | 0.650 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 31 | 0.650 |
Why?
|
| Mutation | 10 | 2019 | 1177 | 0.650 |
Why?
|
| Chemokines, CC | 2 | 2018 | 55 | 0.650 |
Why?
|
| Molecular Motor Proteins | 2 | 2013 | 9 | 0.640 |
Why?
|
| Molecular Sequence Data | 13 | 2015 | 1542 | 0.630 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2020 | 8 | 0.630 |
Why?
|
| Databases, Genetic | 3 | 2010 | 103 | 0.620 |
Why?
|
| Liver Neoplasms | 4 | 2025 | 224 | 0.610 |
Why?
|
| Prostatic Neoplasms | 7 | 2021 | 1092 | 0.610 |
Why?
|
| S Phase | 2 | 2018 | 36 | 0.610 |
Why?
|
| Epidermal Growth Factor | 5 | 2025 | 70 | 0.600 |
Why?
|
| Neoplastic Stem Cells | 2 | 2023 | 99 | 0.580 |
Why?
|
| Fluorescence Resonance Energy Transfer | 4 | 2024 | 56 | 0.580 |
Why?
|
| Osteosarcoma | 1 | 2018 | 30 | 0.570 |
Why?
|
| Vesicular Transport Proteins | 5 | 2025 | 48 | 0.570 |
Why?
|
| Sequence Alignment | 5 | 2021 | 272 | 0.560 |
Why?
|
| Precancerous Conditions | 1 | 2019 | 83 | 0.560 |
Why?
|
| Epithelium | 2 | 2009 | 78 | 0.550 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 100 | 0.550 |
Why?
|
| Drosophila melanogaster | 2 | 2019 | 193 | 0.550 |
Why?
|
| Gastric Mucosa | 3 | 2024 | 65 | 0.540 |
Why?
|
| Decision Making | 1 | 2020 | 249 | 0.540 |
Why?
|
| Microscopy, Fluorescence | 8 | 2014 | 256 | 0.530 |
Why?
|
| Thioglycolates | 2 | 2022 | 2 | 0.520 |
Why?
|
| Chromosomal Instability | 2 | 2016 | 20 | 0.520 |
Why?
|
| Substrate Specificity | 8 | 2024 | 219 | 0.520 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2022 | 10 | 0.520 |
Why?
|
| Protein Conformation | 8 | 2021 | 416 | 0.510 |
Why?
|
| Breast Neoplasms | 5 | 2018 | 1723 | 0.510 |
Why?
|
| Meiosis | 3 | 2025 | 67 | 0.510 |
Why?
|
| Cortactin | 1 | 2016 | 4 | 0.500 |
Why?
|
| Cytoskeleton | 8 | 2025 | 114 | 0.500 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2024 | 91 | 0.490 |
Why?
|
| Protein Phosphatase 1 | 1 | 2016 | 70 | 0.480 |
Why?
|
| Endoplasmic Reticulum | 3 | 2024 | 108 | 0.470 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2015 | 146 | 0.470 |
Why?
|
| Caenorhabditis elegans Proteins | 3 | 2025 | 41 | 0.470 |
Why?
|
| Neoplasm Metastasis | 8 | 2022 | 237 | 0.460 |
Why?
|
| Cells, Cultured | 12 | 2017 | 1621 | 0.460 |
Why?
|
| Adaptor Proteins, Signal Transducing | 4 | 2021 | 213 | 0.460 |
Why?
|
| RNA-Binding Proteins | 2 | 2024 | 161 | 0.460 |
Why?
|
| Models, Chemical | 2 | 2006 | 204 | 0.460 |
Why?
|
| Protein Multimerization | 5 | 2024 | 115 | 0.460 |
Why?
|
| Kidney | 3 | 2007 | 372 | 0.450 |
Why?
|
| Methylation | 7 | 2025 | 119 | 0.450 |
Why?
|
| MicroRNAs | 2 | 2018 | 518 | 0.450 |
Why?
|
| Mice | 19 | 2025 | 6644 | 0.440 |
Why?
|
| Chromosomes | 5 | 2022 | 43 | 0.440 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2015 | 166 | 0.440 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 77 | 0.430 |
Why?
|
| Phosphoric Monoester Hydrolases | 4 | 2010 | 35 | 0.430 |
Why?
|
| Protein Interaction Mapping | 4 | 2012 | 65 | 0.430 |
Why?
|
| Transfection | 11 | 2009 | 532 | 0.430 |
Why?
|
| Histones | 4 | 2022 | 197 | 0.430 |
Why?
|
| Phosphoprotein Phosphatases | 3 | 2026 | 49 | 0.430 |
Why?
|
| Endopeptidases | 2 | 2017 | 64 | 0.420 |
Why?
|
| Aspirin | 1 | 2015 | 89 | 0.420 |
Why?
|
| Sequence Homology, Amino Acid | 7 | 2021 | 267 | 0.420 |
Why?
|
| Prognosis | 9 | 2019 | 861 | 0.410 |
Why?
|
| Multiprotein Complexes | 2 | 2021 | 56 | 0.410 |
Why?
|
| Mitochondrial Proteins | 3 | 2026 | 118 | 0.410 |
Why?
|
| Green Fluorescent Proteins | 8 | 2015 | 209 | 0.410 |
Why?
|
| Chromatin | 3 | 2025 | 186 | 0.410 |
Why?
|
| Acyltransferases | 2 | 2020 | 22 | 0.410 |
Why?
|
| Proteome | 3 | 2012 | 152 | 0.400 |
Why?
|
| Cell Biology | 1 | 2013 | 13 | 0.400 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 133 | 0.390 |
Why?
|
| Blotting, Western | 9 | 2012 | 883 | 0.390 |
Why?
|
| Molecular Biology | 1 | 2013 | 47 | 0.390 |
Why?
|
| Enzyme Inhibitors | 7 | 2016 | 458 | 0.390 |
Why?
|
| Organelles | 2 | 2024 | 20 | 0.390 |
Why?
|
| Threonine | 3 | 2007 | 24 | 0.390 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2009 | 200 | 0.390 |
Why?
|
| Escherichia coli | 3 | 2021 | 460 | 0.380 |
Why?
|
| Cell Membrane Permeability | 3 | 2008 | 57 | 0.380 |
Why?
|
| Calcium-Binding Proteins | 4 | 2018 | 81 | 0.380 |
Why?
|
| Cell Cycle | 6 | 2024 | 346 | 0.370 |
Why?
|
| Antineoplastic Agents | 6 | 2025 | 1019 | 0.370 |
Why?
|
| RNA Interference | 5 | 2019 | 247 | 0.370 |
Why?
|
| 14-3-3 Proteins | 1 | 2012 | 21 | 0.360 |
Why?
|
| Inhibitor of Apoptosis Proteins | 3 | 2010 | 34 | 0.360 |
Why?
|
| Lung Neoplasms | 2 | 2015 | 495 | 0.360 |
Why?
|
| Research | 1 | 2013 | 181 | 0.360 |
Why?
|
| Gene Expression Regulation | 5 | 2022 | 1070 | 0.360 |
Why?
|
| Proteomics | 7 | 2025 | 378 | 0.360 |
Why?
|
| Microfilament Proteins | 4 | 2025 | 72 | 0.360 |
Why?
|
| Killer Cells, Natural | 2 | 2009 | 104 | 0.350 |
Why?
|
| Mesoderm | 2 | 2025 | 73 | 0.350 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 36 | 0.340 |
Why?
|
| Chromatids | 1 | 2010 | 2 | 0.340 |
Why?
|
| Lipoylation | 2 | 2023 | 17 | 0.340 |
Why?
|
| CDC2 Protein Kinase | 3 | 2024 | 19 | 0.330 |
Why?
|
| Immunohistochemistry | 7 | 2011 | 934 | 0.330 |
Why?
|
| Immunoprecipitation | 5 | 2016 | 127 | 0.330 |
Why?
|
| Nephrolithiasis | 3 | 2014 | 3 | 0.330 |
Why?
|
| Glioblastoma | 2 | 2023 | 74 | 0.320 |
Why?
|
| Streptolysins | 2 | 2008 | 4 | 0.320 |
Why?
|
| Interphase | 1 | 2009 | 6 | 0.320 |
Why?
|
| Palmitates | 2 | 2006 | 15 | 0.310 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 3 | 2021 | 8 | 0.310 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2006 | 186 | 0.310 |
Why?
|
| Cryoelectron Microscopy | 3 | 2025 | 50 | 0.310 |
Why?
|
| Chromosome Pairing | 1 | 2009 | 2 | 0.300 |
Why?
|
| cdc42 GTP-Binding Protein | 3 | 2022 | 25 | 0.300 |
Why?
|
| Nerve Tissue Proteins | 4 | 2020 | 386 | 0.300 |
Why?
|
| Software Design | 2 | 2008 | 18 | 0.300 |
Why?
|
| Male | 29 | 2025 | 23409 | 0.300 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2009 | 13 | 0.300 |
Why?
|
| Phagocytosis | 1 | 2009 | 86 | 0.300 |
Why?
|
| Calpain | 2 | 2008 | 35 | 0.300 |
Why?
|
| Apoptosis | 6 | 2023 | 1568 | 0.290 |
Why?
|
| Intracellular Membranes | 2 | 2006 | 36 | 0.290 |
Why?
|
| Neuregulin-1 | 1 | 2009 | 26 | 0.290 |
Why?
|
| Golgi Apparatus | 2 | 2024 | 27 | 0.290 |
Why?
|
| Nuclear Envelope | 3 | 2024 | 10 | 0.290 |
Why?
|
| Achlorhydria | 1 | 2008 | 2 | 0.290 |
Why?
|
| Ubiquitination | 2 | 2024 | 62 | 0.290 |
Why?
|
| Neoplasm Proteins | 4 | 2008 | 228 | 0.290 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2009 | 39 | 0.290 |
Why?
|
| Cell Physiological Phenomena | 1 | 2008 | 9 | 0.290 |
Why?
|
| Software Validation | 1 | 2008 | 3 | 0.280 |
Why?
|
| Pseudopodia | 2 | 2025 | 17 | 0.280 |
Why?
|
| Endothelial Cells | 3 | 2023 | 329 | 0.280 |
Why?
|
| Synaptosomal-Associated Protein 25 | 2 | 2007 | 8 | 0.280 |
Why?
|
| Bacterial Proteins | 3 | 2008 | 595 | 0.280 |
Why?
|
| Cyclin B | 1 | 2008 | 7 | 0.280 |
Why?
|
| RNA, Ribosomal | 2 | 2019 | 31 | 0.280 |
Why?
|
| Caenorhabditis elegans | 3 | 2025 | 80 | 0.280 |
Why?
|
| Ubiquitins | 2 | 2007 | 47 | 0.280 |
Why?
|
| Genomic Instability | 3 | 2016 | 37 | 0.280 |
Why?
|
| Transport Vesicles | 1 | 2008 | 22 | 0.270 |
Why?
|
| Munc18 Proteins | 1 | 2007 | 2 | 0.270 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2007 | 6 | 0.270 |
Why?
|
| Mice, Inbred BALB C | 5 | 2020 | 694 | 0.270 |
Why?
|
| Cyclic AMP | 3 | 2017 | 127 | 0.270 |
Why?
|
| Lymphocytes | 1 | 2008 | 124 | 0.270 |
Why?
|
| Biological Assay | 1 | 2008 | 63 | 0.270 |
Why?
|
| F-Box Proteins | 1 | 2007 | 6 | 0.270 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2007 | 52 | 0.260 |
Why?
|
| Aminopyrine | 5 | 2010 | 5 | 0.260 |
Why?
|
| Bacteriocin Plasmids | 1 | 2006 | 1 | 0.260 |
Why?
|
| Cullin Proteins | 2 | 2024 | 12 | 0.260 |
Why?
|
| Replication Origin | 1 | 2006 | 16 | 0.260 |
Why?
|
| Acetyltransferases | 1 | 2006 | 27 | 0.250 |
Why?
|
| DNA Methylation | 2 | 2007 | 403 | 0.250 |
Why?
|
| Cell Proliferation | 7 | 2024 | 1455 | 0.250 |
Why?
|
| Female | 24 | 2025 | 24698 | 0.250 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2017 | 67 | 0.240 |
Why?
|
| Transcription Factor AP-2 | 1 | 2025 | 4 | 0.240 |
Why?
|
| S-Phase Kinase-Associated Proteins | 1 | 2006 | 23 | 0.240 |
Why?
|
| Myosin Type II | 1 | 2025 | 17 | 0.240 |
Why?
|
| Cell Shape | 1 | 2025 | 42 | 0.240 |
Why?
|
| Penile Neoplasms | 3 | 2011 | 12 | 0.240 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2005 | 3 | 0.240 |
Why?
|
| Risk Assessment | 4 | 2019 | 863 | 0.240 |
Why?
|
| Chromosomes, Fungal | 1 | 2025 | 4 | 0.240 |
Why?
|
| Middle Aged | 23 | 2021 | 12222 | 0.230 |
Why?
|
| Vimentin | 1 | 2025 | 44 | 0.230 |
Why?
|
| Crossing Over, Genetic | 1 | 2025 | 6 | 0.230 |
Why?
|
| Cloning, Molecular | 3 | 2021 | 314 | 0.230 |
Why?
|
| Oxidoreductases | 1 | 2006 | 79 | 0.230 |
Why?
|
| Organogenesis | 1 | 2025 | 16 | 0.230 |
Why?
|
| Crystallography, X-Ray | 6 | 2025 | 280 | 0.230 |
Why?
|
| RNA, Bacterial | 1 | 2025 | 40 | 0.230 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2005 | 3 | 0.230 |
Why?
|
| RNA, Untranslated | 1 | 2025 | 50 | 0.230 |
Why?
|
| Computer Simulation | 4 | 2008 | 408 | 0.230 |
Why?
|
| Phosphoserine | 2 | 2021 | 21 | 0.230 |
Why?
|
| Kupffer Cells | 1 | 2025 | 3 | 0.230 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 863 | 0.230 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2024 | 7 | 0.230 |
Why?
|
| Janus Kinase 1 | 1 | 2025 | 20 | 0.220 |
Why?
|
| Kinetics | 3 | 2021 | 695 | 0.220 |
Why?
|
| Arginine | 2 | 2021 | 75 | 0.220 |
Why?
|
| Small Molecule Libraries | 1 | 2025 | 62 | 0.220 |
Why?
|
| Lamin Type A | 1 | 2024 | 14 | 0.220 |
Why?
|
| Aneuploidy | 1 | 2025 | 24 | 0.220 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2024 | 90 | 0.220 |
Why?
|
| DNA Repair | 2 | 2024 | 198 | 0.220 |
Why?
|
| Amino Acid Substitution | 4 | 2017 | 135 | 0.220 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2024 | 6 | 0.220 |
Why?
|
| Aged | 18 | 2021 | 8214 | 0.220 |
Why?
|
| Disease Progression | 5 | 2017 | 667 | 0.220 |
Why?
|
| Mice, Nude | 4 | 2020 | 408 | 0.220 |
Why?
|
| Internet | 6 | 2010 | 236 | 0.220 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2024 | 7 | 0.220 |
Why?
|
| Abortion, Spontaneous | 1 | 2025 | 27 | 0.220 |
Why?
|
| Embryo, Mammalian | 1 | 2025 | 157 | 0.220 |
Why?
|
| Genome, Human | 1 | 2005 | 144 | 0.220 |
Why?
|
| Stomach | 2 | 2024 | 50 | 0.220 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2024 | 9 | 0.210 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 592 | 0.210 |
Why?
|
| Ribosomal Proteins | 1 | 2024 | 22 | 0.210 |
Why?
|
| Oocytes | 1 | 2025 | 149 | 0.210 |
Why?
|
| Time Factors | 6 | 2020 | 1857 | 0.210 |
Why?
|
| Embryonic Development | 2 | 2025 | 83 | 0.210 |
Why?
|
| Survival Analysis | 4 | 2018 | 368 | 0.210 |
Why?
|
| Candida albicans | 1 | 2025 | 176 | 0.210 |
Why?
|
| Esophageal Neoplasms | 1 | 2025 | 140 | 0.210 |
Why?
|
| Unfolded Protein Response | 1 | 2024 | 22 | 0.210 |
Why?
|
| Interleukin-6 | 1 | 2025 | 165 | 0.210 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2020 | 88 | 0.210 |
Why?
|
| Bone Neoplasms | 3 | 2013 | 49 | 0.210 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 5 | 0.200 |
Why?
|
| Peptides | 3 | 2021 | 372 | 0.200 |
Why?
|
| Thrombomodulin | 1 | 2023 | 5 | 0.200 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 512 | 0.200 |
Why?
|
| Case-Control Studies | 6 | 2016 | 1285 | 0.200 |
Why?
|
| RNA | 1 | 2025 | 266 | 0.200 |
Why?
|
| Ubiquitin | 1 | 2023 | 81 | 0.200 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2022 | 6 | 0.200 |
Why?
|
| Genomics | 1 | 2005 | 293 | 0.190 |
Why?
|
| Macrophages | 3 | 2018 | 529 | 0.190 |
Why?
|
| Spores, Fungal | 1 | 2022 | 21 | 0.190 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2022 | 14 | 0.190 |
Why?
|
| RNA, Small Nuclear | 1 | 2022 | 10 | 0.190 |
Why?
|
| Down-Regulation | 4 | 2025 | 456 | 0.190 |
Why?
|
| Cyclin B2 | 1 | 2022 | 1 | 0.190 |
Why?
|
| Evolution, Molecular | 2 | 2019 | 307 | 0.190 |
Why?
|
| Nomograms | 2 | 2012 | 14 | 0.190 |
Why?
|
| Tubulin | 1 | 2022 | 96 | 0.180 |
Why?
|
| Adenomatous Polyps | 2 | 2013 | 13 | 0.180 |
Why?
|
| Virus Internalization | 1 | 2022 | 36 | 0.180 |
Why?
|
| Homeostasis | 2 | 2020 | 192 | 0.180 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 64 | 0.180 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 38 | 0.180 |
Why?
|
| Bayes Theorem | 3 | 2006 | 126 | 0.180 |
Why?
|
| Glioma | 1 | 2023 | 96 | 0.180 |
Why?
|
| Up-Regulation | 4 | 2018 | 536 | 0.180 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 64 | 0.180 |
Why?
|
| Morphogenesis | 1 | 2021 | 48 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2021 | 68 | 0.170 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 140 | 0.170 |
Why?
|
| Liver Regeneration | 1 | 2020 | 2 | 0.170 |
Why?
|
| User-Computer Interface | 4 | 2009 | 74 | 0.170 |
Why?
|
| Lymph Node Excision | 2 | 2011 | 25 | 0.160 |
Why?
|
| DNA, Mitochondrial | 2 | 2013 | 191 | 0.160 |
Why?
|
| China | 2 | 2013 | 229 | 0.160 |
Why?
|
| Enzyme Activation | 3 | 2017 | 462 | 0.160 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 116 | 0.160 |
Why?
|
| Ultrasound, High-Intensity Focused, Transrectal | 1 | 2019 | 1 | 0.160 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2020 | 32 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 141 | 0.160 |
Why?
|
| TRPM Cation Channels | 1 | 2020 | 40 | 0.160 |
Why?
|
| Cell Survival | 3 | 2020 | 945 | 0.150 |
Why?
|
| Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2019 | 4 | 0.150 |
Why?
|
| Genes, Mitochondrial | 1 | 2019 | 14 | 0.150 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2019 | 12 | 0.150 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 84 | 0.150 |
Why?
|
| Adenosine Triphosphate | 3 | 2008 | 206 | 0.150 |
Why?
|
| Glutathione Transferase | 3 | 2004 | 90 | 0.150 |
Why?
|
| Structural Homology, Protein | 1 | 2019 | 14 | 0.150 |
Why?
|
| Treatment Outcome | 4 | 2019 | 1604 | 0.150 |
Why?
|
| Stem Cell Niche | 1 | 2018 | 11 | 0.150 |
Why?
|
| Tyrosine | 2 | 2011 | 120 | 0.140 |
Why?
|
| Protein Biosynthesis | 1 | 2019 | 132 | 0.140 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2018 | 32 | 0.140 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2018 | 47 | 0.140 |
Why?
|
| Glucosyltransferases | 1 | 2018 | 7 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2012 | 241 | 0.140 |
Why?
|
| Adipose Tissue | 1 | 2019 | 182 | 0.140 |
Why?
|
| ran GTP-Binding Protein | 1 | 2018 | 4 | 0.140 |
Why?
|
| DNA Helicases | 2 | 2023 | 48 | 0.140 |
Why?
|
| Nucleosomes | 1 | 2018 | 30 | 0.140 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2018 | 34 | 0.140 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gs | 1 | 2017 | 3 | 0.140 |
Why?
|
| Chromogranins | 1 | 2017 | 5 | 0.140 |
Why?
|
| Dyneins | 2 | 2008 | 8 | 0.140 |
Why?
|
| Burns | 1 | 2017 | 10 | 0.140 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2017 | 13 | 0.140 |
Why?
|
| Ligands | 3 | 2025 | 388 | 0.130 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2017 | 160 | 0.130 |
Why?
|
| Neoplasm Staging | 4 | 2019 | 374 | 0.130 |
Why?
|
| Spleen | 1 | 2017 | 204 | 0.130 |
Why?
|
| STAT1 Transcription Factor | 1 | 2017 | 34 | 0.130 |
Why?
|
| Adult | 15 | 2020 | 13872 | 0.130 |
Why?
|
| Protein Isoforms | 2 | 2009 | 139 | 0.130 |
Why?
|
| src Homology Domains | 1 | 2016 | 14 | 0.130 |
Why?
|
| Cluster Analysis | 2 | 2008 | 207 | 0.130 |
Why?
|
| Conserved Sequence | 2 | 2008 | 122 | 0.130 |
Why?
|
| Dystrophin-Associated Proteins | 1 | 2016 | 5 | 0.130 |
Why?
|
| NADH Dehydrogenase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2016 | 6 | 0.120 |
Why?
|
| Integrins | 2 | 2018 | 54 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2014 | 1003 | 0.120 |
Why?
|
| Retinoblastoma-Binding Protein 2 | 1 | 2016 | 2 | 0.120 |
Why?
|
| Pyridines | 2 | 2011 | 139 | 0.120 |
Why?
|
| Dogs | 2 | 2025 | 204 | 0.120 |
Why?
|
| STAT3 Transcription Factor | 1 | 2017 | 102 | 0.120 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 587 | 0.120 |
Why?
|
| SUMO-1 Protein | 2 | 2006 | 16 | 0.120 |
Why?
|
| Interferon-gamma | 1 | 2017 | 269 | 0.120 |
Why?
|
| Cytoprotection | 1 | 2015 | 36 | 0.120 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 188 | 0.120 |
Why?
|
| Origin Recognition Complex | 1 | 2016 | 23 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 518 | 0.120 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2007 | 51 | 0.120 |
Why?
|
| Microscopy, Confocal | 2 | 2007 | 224 | 0.120 |
Why?
|
| Cholinesterases | 1 | 2015 | 2 | 0.120 |
Why?
|
| Amnesia | 1 | 2015 | 8 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 2 | 2025 | 50 | 0.120 |
Why?
|
| Carbon Radioisotopes | 2 | 2008 | 15 | 0.120 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 58 | 0.120 |
Why?
|
| Membrane Fusion | 2 | 2008 | 11 | 0.120 |
Why?
|
| Monocytes | 1 | 2017 | 277 | 0.110 |
Why?
|
| Serine | 2 | 2007 | 79 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 146 | 0.110 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 432 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 291 | 0.110 |
Why?
|
| Plasmids | 1 | 2016 | 244 | 0.110 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2019 | 199 | 0.110 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 2 | 2022 | 10 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2015 | 152 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2021 | 41 | 0.110 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 532 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 3 | 2024 | 196 | 0.110 |
Why?
|
| Myosins | 1 | 2014 | 35 | 0.110 |
Why?
|
| DNA | 4 | 2024 | 592 | 0.110 |
Why?
|
| Sex Distribution | 1 | 2015 | 224 | 0.110 |
Why?
|
| Fibrinogen | 1 | 2014 | 24 | 0.110 |
Why?
|
| Heterochromatin | 1 | 2014 | 19 | 0.110 |
Why?
|
| Apolipoprotein A-I | 1 | 2014 | 24 | 0.110 |
Why?
|
| Angiotensinogen | 1 | 2014 | 6 | 0.110 |
Why?
|
| Sepsis | 1 | 2015 | 90 | 0.110 |
Why?
|
| RNA, Messenger | 4 | 2022 | 1271 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2014 | 51 | 0.110 |
Why?
|
| Aged, 80 and over | 6 | 2013 | 2853 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 306 | 0.100 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 44 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2015 | 129 | 0.100 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 218 | 0.100 |
Why?
|
| Gene Expression | 4 | 2021 | 701 | 0.100 |
Why?
|
| International Cooperation | 1 | 2013 | 52 | 0.100 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2019 | 110 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2013 | 63 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2013 | 89 | 0.100 |
Why?
|
| Mutagenesis | 2 | 2021 | 91 | 0.100 |
Why?
|
| Mammals | 2 | 2024 | 112 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2021 | 2544 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 2012 | 20 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2012 | 161 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2021 | 518 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2012 | 8 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 2 | 2010 | 34 | 0.090 |
Why?
|
| Liver | 1 | 2015 | 511 | 0.090 |
Why?
|
| Prostatectomy | 1 | 2012 | 70 | 0.090 |
Why?
|
| Phenotype | 4 | 2017 | 780 | 0.090 |
Why?
|
| Bone and Bones | 1 | 2013 | 114 | 0.090 |
Why?
|
| Drainage | 1 | 2011 | 12 | 0.090 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2011 | 8 | 0.090 |
Why?
|
| Research Personnel | 1 | 2013 | 206 | 0.090 |
Why?
|
| Cell Differentiation | 4 | 2023 | 638 | 0.090 |
Why?
|
| COS Cells | 1 | 2011 | 68 | 0.090 |
Why?
|
| Immunoblotting | 2 | 2009 | 181 | 0.090 |
Why?
|
| Biopsy | 2 | 2010 | 177 | 0.090 |
Why?
|
| Angiopoietin-2 | 1 | 2011 | 5 | 0.090 |
Why?
|
| Morpholines | 2 | 2009 | 72 | 0.090 |
Why?
|
| Caspase 3 | 2 | 2009 | 227 | 0.090 |
Why?
|
| Benzenesulfonates | 1 | 2011 | 9 | 0.090 |
Why?
|
| Chromones | 2 | 2009 | 53 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 2 | 2025 | 526 | 0.090 |
Why?
|
| Cytoplasm | 3 | 2007 | 154 | 0.090 |
Why?
|
| Protein Structure, Quaternary | 2 | 2011 | 69 | 0.090 |
Why?
|
| Reproducibility of Results | 3 | 2009 | 1081 | 0.090 |
Why?
|
| Cell Adhesion | 2 | 2011 | 238 | 0.090 |
Why?
|
| Mice, SCID | 1 | 2011 | 158 | 0.080 |
Why?
|
| Postoperative Complications | 1 | 2012 | 263 | 0.080 |
Why?
|
| Autoantigens | 1 | 2011 | 87 | 0.080 |
Why?
|
| Nitroso Compounds | 1 | 2010 | 12 | 0.080 |
Why?
|
| Proton-Translocating ATPases | 1 | 2010 | 17 | 0.080 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 61 | 0.080 |
Why?
|
| Antigens, Neoplasm | 2 | 2008 | 90 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2008 | 197 | 0.080 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2009 | 8 | 0.080 |
Why?
|
| Bacterial Toxins | 1 | 2010 | 50 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 2010 | 71 | 0.080 |
Why?
|
| Genome, Fungal | 1 | 2009 | 28 | 0.080 |
Why?
|
| Molecular Weight | 1 | 2009 | 168 | 0.080 |
Why?
|
| Ovarian Neoplasms | 1 | 2014 | 415 | 0.080 |
Why?
|
| Dimerization | 1 | 2009 | 112 | 0.080 |
Why?
|
| Peptide Hydrolases | 2 | 2009 | 44 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 35 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 347 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 98 | 0.080 |
Why?
|
| Computer Graphics | 1 | 2009 | 18 | 0.070 |
Why?
|
| Prostatic Hyperplasia | 1 | 2009 | 32 | 0.070 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2009 | 18 | 0.070 |
Why?
|
| Enzymes | 1 | 2009 | 35 | 0.070 |
Why?
|
| Endocytosis | 1 | 2009 | 118 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2009 | 74 | 0.070 |
Why?
|
| Antibodies | 1 | 2009 | 144 | 0.070 |
Why?
|
| Sirolimus | 1 | 2009 | 70 | 0.070 |
Why?
|
| Chemotaxis | 1 | 2009 | 68 | 0.070 |
Why?
|
| Saccharomycetales | 1 | 2008 | 8 | 0.070 |
Why?
|
| Gastritis, Atrophic | 1 | 2008 | 13 | 0.070 |
Why?
|
| RNA, Catalytic | 1 | 2008 | 5 | 0.070 |
Why?
|
| Serpins | 1 | 2008 | 27 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 58 | 0.070 |
Why?
|
| Cadherins | 1 | 2009 | 102 | 0.070 |
Why?
|
| Phosphopeptides | 1 | 2008 | 5 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2009 | 174 | 0.070 |
Why?
|
| Cyclin B1 | 1 | 2008 | 18 | 0.070 |
Why?
|
| Carcinoma | 1 | 2009 | 108 | 0.070 |
Why?
|
| Cell Fractionation | 1 | 2008 | 29 | 0.070 |
Why?
|
| Potassium Chloride | 1 | 2008 | 24 | 0.070 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2008 | 47 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 515 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 77 | 0.070 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2007 | 9 | 0.070 |
Why?
|
| Genetic Variation | 1 | 2010 | 430 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2007 | 13 | 0.070 |
Why?
|
| Peptide Fragments | 2 | 2012 | 307 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2008 | 154 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 423 | 0.070 |
Why?
|
| Response Elements | 1 | 2007 | 55 | 0.070 |
Why?
|
| Cell Communication | 1 | 2008 | 114 | 0.070 |
Why?
|
| Microscopy, Atomic Force | 1 | 2007 | 61 | 0.070 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 638 | 0.060 |
Why?
|
| Bacteriophage lambda | 1 | 2006 | 12 | 0.060 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2008 | 159 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2008 | 186 | 0.060 |
Why?
|
| CpG Islands | 1 | 2007 | 109 | 0.060 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 25 | 0.060 |
Why?
|
| Staurosporine | 1 | 2006 | 38 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2007 | 183 | 0.060 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2007 | 89 | 0.060 |
Why?
|
| Risk Factors | 2 | 2021 | 3994 | 0.060 |
Why?
|
| Protein Folding | 1 | 2007 | 123 | 0.060 |
Why?
|
| Aluminum Compounds | 1 | 2006 | 10 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2021 | 93 | 0.060 |
Why?
|
| Fluorides | 1 | 2006 | 19 | 0.060 |
Why?
|
| Granulosa Cells | 1 | 2006 | 44 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2006 | 53 | 0.060 |
Why?
|
| Intermediate Filaments | 1 | 2025 | 20 | 0.060 |
Why?
|
| Adenoviridae | 4 | 2008 | 62 | 0.060 |
Why?
|
| DNA, Bacterial | 1 | 2006 | 206 | 0.060 |
Why?
|
| Histidine | 1 | 2025 | 43 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2013 | 440 | 0.060 |
Why?
|
| Biological Transport | 2 | 2003 | 204 | 0.060 |
Why?
|
| Superoxide Dismutase | 1 | 2006 | 158 | 0.060 |
Why?
|
| Synaptonemal Complex | 1 | 2025 | 1 | 0.060 |
Why?
|
| Endoderm | 1 | 2025 | 2 | 0.060 |
Why?
|
| Candida | 1 | 2025 | 42 | 0.060 |
Why?
|
| Immunity, Mucosal | 1 | 2025 | 53 | 0.060 |
Why?
|
| Adherens Junctions | 1 | 2025 | 11 | 0.060 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2005 | 19 | 0.060 |
Why?
|
| SNARE Proteins | 2 | 2002 | 7 | 0.060 |
Why?
|
| Calcium | 1 | 2008 | 491 | 0.060 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 2002 | 14 | 0.060 |
Why?
|
| Genetic Vectors | 2 | 2021 | 165 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 1 | 2006 | 139 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 196 | 0.060 |
Why?
|
| Thiazoles | 2 | 2004 | 76 | 0.060 |
Why?
|
| Microtubule-Organizing Center | 1 | 2025 | 3 | 0.060 |
Why?
|
| Fungal Proteins | 1 | 2025 | 142 | 0.060 |
Why?
|
| Candidiasis | 1 | 2025 | 89 | 0.060 |
Why?
|
| Nuclear Lamina | 1 | 2024 | 2 | 0.060 |
Why?
|
| Metaplasia | 1 | 2024 | 39 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2025 | 134 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 611 | 0.050 |
Why?
|
| Intestines | 1 | 2024 | 71 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2025 | 154 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2025 | 192 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2025 | 108 | 0.050 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2004 | 34 | 0.050 |
Why?
|
| Aspergillus nidulans | 1 | 2004 | 7 | 0.050 |
Why?
|
| Acylation | 1 | 2024 | 11 | 0.050 |
Why?
|
| Sister Chromatid Exchange | 1 | 2004 | 6 | 0.050 |
Why?
|
| Ribosomes | 1 | 2024 | 35 | 0.050 |
Why?
|
| Nocodazole | 1 | 2004 | 8 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2004 | 52 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2004 | 28 | 0.050 |
Why?
|
| Proline | 1 | 2024 | 40 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2025 | 169 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 209 | 0.050 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2006 | 220 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 2 | 2014 | 147 | 0.050 |
Why?
|
| Phylogeny | 1 | 2008 | 769 | 0.050 |
Why?
|
| Heart | 1 | 2025 | 184 | 0.050 |
Why?
|
| Histamine Release | 1 | 2003 | 1 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2024 | 137 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 196 | 0.050 |
Why?
|
| Diacetyl | 1 | 2003 | 2 | 0.050 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2003 | 3 | 0.050 |
Why?
|
| Nonmuscle Myosin Type IIB | 1 | 2003 | 5 | 0.050 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2003 | 78 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2025 | 300 | 0.050 |
Why?
|
| SOXC Transcription Factors | 1 | 2023 | 3 | 0.050 |
Why?
|
| Rats | 3 | 2006 | 3735 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2023 | 83 | 0.050 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 102 | 0.050 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Ethylmaleimide | 1 | 2002 | 8 | 0.050 |
Why?
|
| SMN Complex Proteins | 1 | 2022 | 2 | 0.050 |
Why?
|
| Base Sequence | 2 | 2019 | 983 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2022 | 28 | 0.050 |
Why?
|
| Nucleotides | 1 | 2022 | 37 | 0.050 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 67 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2003 | 64 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2022 | 9 | 0.050 |
Why?
|
| Bucladesine | 1 | 2002 | 10 | 0.050 |
Why?
|
| Anti-Ulcer Agents | 1 | 2002 | 7 | 0.050 |
Why?
|
| Androstadienes | 1 | 2002 | 19 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 44 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2010 | 455 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2002 | 33 | 0.040 |
Why?
|
| ROC Curve | 2 | 2015 | 159 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2021 | 37 | 0.040 |
Why?
|
| Forecasting | 2 | 2012 | 136 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 1035 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 224 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2021 | 48 | 0.040 |
Why?
|
| Protein Structure, Secondary | 2 | 2012 | 182 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2011 | 1600 | 0.040 |
Why?
|
| Logistic Models | 2 | 2015 | 1009 | 0.040 |
Why?
|
| Inguinal Canal | 2 | 2011 | 4 | 0.040 |
Why?
|
| Eukaryotic Cells | 2 | 2012 | 35 | 0.040 |
Why?
|
| SEER Program | 1 | 2021 | 164 | 0.040 |
Why?
|
| Cell Death | 1 | 2021 | 278 | 0.040 |
Why?
|
| Cholesterol | 1 | 2022 | 232 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 105 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 60 | 0.040 |
Why?
|
| Luminescent Proteins | 3 | 2005 | 68 | 0.040 |
Why?
|
| Chaetomium | 1 | 2019 | 2 | 0.040 |
Why?
|
| Pregnancy | 1 | 2025 | 1772 | 0.040 |
Why?
|
| Caseins | 2 | 2009 | 15 | 0.040 |
Why?
|
| Probability | 2 | 2009 | 82 | 0.040 |
Why?
|
| Actomyosin | 1 | 2018 | 7 | 0.040 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 55 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2012 | 465 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2018 | 59 | 0.030 |
Why?
|
| G1 Phase | 1 | 2017 | 31 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 42 | 0.030 |
Why?
|
| Venoms | 1 | 2017 | 18 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2017 | 7 | 0.030 |
Why?
|
| Zebrafish | 1 | 2018 | 146 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2017 | 8 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2017 | 64 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 1766 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 2016 | 2 | 0.030 |
Why?
|
| Cytochromes b | 1 | 2016 | 8 | 0.030 |
Why?
|
| Electron Transport Complex IV | 1 | 2016 | 41 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2016 | 45 | 0.030 |
Why?
|
| Adenylate Kinase | 1 | 2015 | 14 | 0.030 |
Why?
|
| Tunicamycin | 1 | 2015 | 21 | 0.030 |
Why?
|
| Isoenzymes | 2 | 2008 | 168 | 0.030 |
Why?
|
| Flow Cytometry | 2 | 2009 | 411 | 0.030 |
Why?
|
| APACHE | 1 | 2015 | 6 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2015 | 12 | 0.030 |
Why?
|
| Glasgow Coma Scale | 1 | 2015 | 21 | 0.030 |
Why?
|
| Patient Admission | 1 | 2015 | 50 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 458 | 0.030 |
Why?
|
| Autophagy | 1 | 2015 | 140 | 0.030 |
Why?
|
| Alpha-Globulins | 1 | 2014 | 4 | 0.030 |
Why?
|
| Protein Carbonylation | 1 | 2014 | 8 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2020 | 1869 | 0.030 |
Why?
|
| Creatinine | 1 | 2014 | 102 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 167 | 0.030 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 29 | 0.020 |
Why?
|
| R-SNARE Proteins | 2 | 2002 | 5 | 0.020 |
Why?
|
| Cystatin M | 1 | 2012 | 1 | 0.020 |
Why?
|
| Fanconi Anemia | 1 | 2012 | 8 | 0.020 |
Why?
|
| Inflammation | 1 | 2017 | 758 | 0.020 |
Why?
|
| Surface Properties | 1 | 2012 | 160 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2013 | 490 | 0.020 |
Why?
|
| Prostate-Specific Antigen | 1 | 2012 | 147 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 2011 | 4 | 0.020 |
Why?
|
| Phenylurea Compounds | 1 | 2011 | 18 | 0.020 |
Why?
|
| Thermodynamics | 1 | 2012 | 229 | 0.020 |
Why?
|
| Niacinamide | 1 | 2011 | 16 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2011 | 75 | 0.020 |
Why?
|
| Marine Toxins | 1 | 2010 | 17 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 26 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2011 | 116 | 0.020 |
Why?
|
| Systems Integration | 1 | 2010 | 16 | 0.020 |
Why?
|
| Oxazoles | 1 | 2010 | 19 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2010 | 95 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 678 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 91 | 0.020 |
Why?
|
| Incidence | 1 | 2012 | 1078 | 0.020 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2009 | 1 | 0.020 |
Why?
|
| Young Adult | 2 | 2011 | 5080 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2009 | 59 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2010 | 506 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2009 | 81 | 0.020 |
Why?
|
| Urologic Surgical Procedures, Male | 1 | 2008 | 3 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 28 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 24 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2008 | 62 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 53 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 113 | 0.020 |
Why?
|
| Trypsin | 1 | 2008 | 40 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 173 | 0.020 |
Why?
|
| Zirconium | 1 | 2008 | 11 | 0.020 |
Why?
|
| Cattle | 1 | 2009 | 498 | 0.020 |
Why?
|
| Survival Rate | 1 | 2008 | 355 | 0.020 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2007 | 4 | 0.020 |
Why?
|
| Phosphatidylserines | 1 | 2006 | 22 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2006 | 48 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2006 | 34 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2006 | 60 | 0.020 |
Why?
|
| Blood Proteins | 1 | 2006 | 77 | 0.020 |
Why?
|
| Genistein | 1 | 2006 | 45 | 0.020 |
Why?
|
| Cell Surface Extensions | 1 | 2005 | 9 | 0.010 |
Why?
|
| Vacuoles | 1 | 2005 | 22 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 183 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 20 | 0.010 |
Why?
|
| Agar | 1 | 2004 | 9 | 0.010 |
Why?
|
| Tetrazolium Salts | 1 | 2004 | 36 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 652 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2004 | 25 | 0.010 |
Why?
|
| Artificial Intelligence | 1 | 2006 | 112 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 95 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2004 | 49 | 0.010 |
Why?
|
| Fluorouracil | 1 | 2004 | 47 | 0.010 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2004 | 51 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2004 | 97 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 88 | 0.010 |
Why?
|
| Cholinesterase Reactivators | 1 | 2003 | 4 | 0.010 |
Why?
|
| Syntaxin 1 | 1 | 2002 | 2 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 98 | 0.010 |
Why?
|
| Tetanus Toxin | 1 | 2002 | 3 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2002 | 143 | 0.010 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 61 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2002 | 168 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2002 | 240 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1124 | 0.010 |
Why?
|